This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2021.
Company Filing History:
1 out of 5,383 
1 out of 8,807 
Years Active: 2021
Title: The Innovative Contributions of Ina Attree
Introduction
Ina Attree is a notable inventor based in Saint Martin d'Hères, France. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit pathogenic infections. Her work is characterized by a focus on innovative solutions to combat bacterial virulence.
Latest Patents
Ina Attree holds a patent for "Pseudomonas aeruginosa inhibitor compounds." This invention relates to a method of identifying molecules that inhibit the virulence machinery of Pseudomonas aeruginosa. The patent also encompasses novel compounds that can be used for preventing and/or treating infections caused by this pathogenic bacterium. Additionally, it includes pharmaceutical compositions aimed at addressing such infections.
Career Highlights
Throughout her career, Ina has worked with prestigious organizations, including the Centre National de la Recherche Scientifique and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. These institutions have provided her with a platform to advance her research and contribute to significant scientific advancements.
Collaborations
Ina has collaborated with esteemed colleagues, including Yung-Sing Wong and Sophie Ple. These partnerships have enriched her research endeavors and fostered a collaborative environment for innovation.
Conclusion
Ina Attree's work exemplifies the spirit of innovation in the field of pharmaceutical sciences. Her contributions, particularly in the development of compounds to combat bacterial infections, highlight the importance of research and collaboration in addressing public health challenges.